IGF1 and colorectal carcinoma: The current clinical practice for colorectal cancer surveillance in individuals with acromegaly and increased blood IGF1 levels is augmented by our findings. Our results support the already known theory of the possible causal relation between IGF1 (which is elevated in acromegaly) and the high incidence of CRC reported in acromegalic patients.